Literature DB >> 1716963

Two different forms of homozygous sickle cell disease occur in Saudi Arabia.

M A Padmos1, G T Roberts, K Sackey, A Kulozik, S Bail, J S Morris, B E Serjeant, G R Serjeant.   

Abstract

Haematological, clinical and some molecular genetic features of homozygous sickle cell (SS) disease in Saudi Arabia have been compared in 33 patients from the Eastern Province (Eastern) and 30 from the South Western Province (Western). Eastern patients all had the Asian beta globin haplotype whereas Western patients were more variable but predominantly of the Benin haplotype. Eastern patients had more deletional alpha thalassaemia, higher total haemoglobin and fetal haemoglobin levels, and lower HbA2, mean cell volume, reticulocytes, and platelet counts. Clinically, Eastern patients had a greater persistence of splenomegaly, a more normal body build and greater subscapular skin fold thickness, and Western patients had more dactylitis and acute chest syndrome. Painful crises and avascular necrosis of the femoral head were common and occurred equally in both groups. The disease in the Eastern province has many mild features consistent with the higher HbF levels and more frequent alpha thalassaemia but bone pathology (painful crises, avascular necrosis of the femoral head, osteomyelitis) remains common. The disease in the West is more severe consistent with the Benin haplotype suggesting an African origin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716963     DOI: 10.1111/j.1365-2141.1991.tb08013.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  30 in total

Review 1.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

Review 2.  Fetal hemoglobin in sickle cell anemia.

Authors:  Idowu Akinsheye; Abdulrahman Alsultan; Nadia Solovieff; Duyen Ngo; Clinton T Baldwin; Paola Sebastiani; David H K Chui; Martin H Steinberg
Journal:  Blood       Date:  2011-04-13       Impact factor: 22.113

Review 3.  The natural history of sickle cell disease.

Authors:  Graham R Serjeant
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

4.  Transfusion in sickle cell disease: experience from a Gujarat centre.

Authors:  Vishal Mehta; Abhishek Mistry; Bhavesh Raicha; Yazdi Italia; Graham Serjeant
Journal:  Indian J Pediatr       Date:  2013-07-20       Impact factor: 1.967

5.  Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agents.

Authors:  A M Omar; M A Mahran; M S Ghatge; N Chowdhury; F H A Bamane; M E El-Araby; O Abdulmalik; M K Safo
Journal:  Org Biomol Chem       Date:  2015-06-14       Impact factor: 3.876

6.  Sickle Cell Disease in Central India: A Potentially Severe Syndrome.

Authors:  Dipty Jain; Vinit Warthe; Paridhi Dayama; Dilip Sarate; Roshan Colah; Pallavi Mehta; Graham Serjeant
Journal:  Indian J Pediatr       Date:  2016-04-07       Impact factor: 1.967

7.  Guidelines for the fetal diagnosis of globin gene disorders. Globin Gene Disorder Working Party of the BCSH General Haematology Task Force.

Authors: 
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

8.  Priapism in Homozygous Sickle Cell Disease: A 40-year Study of the Natural History.

Authors:  G Serjeant; I Hambleton
Journal:  West Indian Med J       Date:  2015-04-27       Impact factor: 0.171

Review 9.  Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.

Authors:  Martin K Safo; Gregory J Kato
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-21       Impact factor: 3.722

10.  Appendectomy during pregnancy in sickle cell disease patients.

Authors:  Abdulrahman S Al-Mulhim
Journal:  Saudi J Gastroenterol       Date:  2008-07       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.